Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Purchase | 2024-04-15 06:04 am | Oncocyte Corp | OCX | Riggs Josh CEO and President | 3,390 | $2.95 | $10,001 | 3,505 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-20 Option Award | 2024-05-22 4:56 pm | N/A 2034-05-20 | Oncocyte Corp | OCX | Riggs Josh CEO and President | 90,000 | $0 | 90,000 (Direct) | View |
| 2023-08-15 Option Award | 2023-08-17 6:57 pm | N/A 2033-08-15 | Oncocyte Corp | OCX | Riggs Josh CEO and President | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 4:05 pm | N/A 2033-06-09 | Oncocyte Corp | OCX | Riggs Josh CEO and President | 1,150,000 | $0 | 1,150,000 (Direct) | View |
| 2023-02-24 Option Award | 2023-02-28 5:59 pm | N/A 2033-02-24 | Oncocyte Corp | OCX | Riggs Josh CEO | 116,426 | $0 | 116,426 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-19 5:18 pm | N/A 2033-01-17 | Oncocyte Corp | OCX | Riggs Josh Interim CEO | 257,485 | $0 | 257,485 (Direct) | View |
Ownership | 2022-12-09 8:19 pm | N/A N/A | Oncocyte Corp | OCX | Riggs Josh Interim CEO | 0 | $0 | 467,320 (Direct) | View |